{
    "nct_id": "NCT03648073",
    "official_title": "[68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma to Assess the Feasibility of Targeted Radionuclide Therapy With Somatostatin Receptor Ligands",
    "inclusion_criteria": "* Known diagnosis of hepatocellular carcinoma, either by imaging criteria or pathology on biopsy\n* Standard of care liver MRI or CT demonstrating viable HCC based on arterial contrast enhancement measuring at least 1.5 cm in largest axial dimension\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 90 Years",
    "exclusion_criteria": "* History of neuroendocrine tumor or other SSTR-positive tumor\n* Interval locoregional therapy or new systemic therapy between standard of care liver MRI or CT study showing viable HCC and [68Ga]DOTATATE-PET/MRI",
    "miscellaneous_criteria": ""
}